MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma

Treatment with immune checkpoint inhibitors induces a durable response in some patients with non‐small‐cell lung cancer, but eventually gives rise to drug resistance. Upregulation of CD155 expression is implicated as one mechanism of resistance to programmed death receptor‐1 (PD‐1)/PD‐1 ligand (PD‐L...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanishi, Takayuki, Yoneshima, Yasuto, Okamura, Koji, Yanagihara, Toyoshi, Hashisako, Mikiko, Iwasaki, Takeshi, Haratake, Naoki, Mizusaki, Shun, Ota, Keiichi, Iwama, Eiji, Takenaka, Tomoyoshi, Tanaka, Kentaro, Yoshizumi, Tomoharu, Oda, Yoshinao, Okamoto, Isamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551600/
https://www.ncbi.nlm.nih.gov/pubmed/37565582
http://dx.doi.org/10.1111/cas.15921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551600/
https://www.ncbi.nlm.nih.gov/pubmed/37565582
http://dx.doi.org/10.1111/cas.15921

Ejemplares similares